Nancy Cappello, Ph.D., executive director and founder of Are You Dense Inc. and Are You Dense Advocacy, explains how a personalized breast screening program can improve cancer detection for women with dense breasts at the 2017 AHRA annual meeting in Anaheim.
MRI Breast
-
-
October 20, 2016 — An annual mammogram is recommended after treatment for breast cancer, but nearly one-third of women diagnosed with breast...
-
A magnetic resonance (MR) breast imaging technique that uses no ionizing radiation or contrast agent could reduce unnecessary biopsies by providing additional information about suspicious findings on X-ray screening mammography, according to a new study published online in the journal Radiology...
-
Researchers have shown that magnetic resonance imaging (MRI) can detect the earliest signs of breast cancer recurrence and fast-growing tumors. Their approach detects micrometastases, breakaway tumor cells with the potential to develop into dangerous secondary breast cancer tumors elsewhere in...
-
Siemens Healthcare has announced that the Food and Drug Administration (FDA) has cleared the Magnetom Prisma, a 3 Tesla (3T) magnetic resonance imaging (MRI) scanner capable of extraordinarily high spatial and temporal resolution to achieve outstanding image quality, particularly in highly...
Videos | Breast Imaging | July 28, 2017
Nancy Cappello, Ph.D., executive director and founder of Are You Dense Inc. and Are You Dense Advocacy, explains how...
News | MRI Breast | March 13, 2017
March 13, 2017 — A new study shows women at high risk for breast cancer were more likely to return for additional...
Images in a 55-year-old screening participant. (a, b) Normal digital full-field mediolateral oblique (a) and craniocaudal (b) mammograms (BI-RADS category 1) show a heterogeneously dense breast (ACR category C). (c) Screening ultrasound image shows normal findings (BI-RADS category 1). (d) MR-guided biopsy enabled us to confirm the presence of an invasive high-grade triple-negative cancer (no special type [NST], pT1b, N0, M0). (d) Breast MR image shows a suspicious enhancing mass (arrow) in the left breast (BI-RADS category 5). Image courtesy of the Radiological Society of North America.
News | MRI Breast | February 21, 2017
February 21, 2017 — Magnetic resonance imaging (MRI) screening improves early diagnosis of...
News | MRI Breast | February 10, 2017
February 10, 2017 — A new method for screening women with dense breast tissue may potentially save thousands of...
News | MRI Breast | June 27, 2016
June 27, 2016 — A new phase 1 clinical trial from Brigham and Women's Hospital published in Radiology on June 22...
Graphic courtesy Pixabay
Blog | Imaging | June 01, 2016
Cancer screening is the only circumstance in which apparently healthy people subject themselves purposely to an...
Differences in dynamic textural patterns are apparent between a patient with a low recurrence score, left, and a patient with a high recurrence score, right. Image courtesy of Nature Scientific Reports
News | MRI Breast | February 19, 2016
February 19, 2016 — A new way to analyze ...
Molecular imaging of the GRPR biomarker on mice xenografted with PC3 and H441 cells by T1-weighted spin echo MR imaging and NIR imaging.
News | Magnetic Resonance Imaging (MRI) | December 29, 2015
December 29, 2015 — A method to better trace changes in cancers and treatment of the prostate and lung without the...
News | MRI Breast | November 25, 2015
November 25, 2015 — Additional breast cancers found with magnetic resonance imaging (MRI) are sometimes larger and...
Image courtesy of Hologic
News | Breast Imaging | November 13, 2015
November 13, 2015 — The new peer-reviewed self-assessment CPI Breast Imaging Module 2015 contains the American...
University of Oklahoma professors Bin Zheng, Ph.D., (left) and Hong Liu, Ph.D., are developing innovative imaging technology and quantitative image processing methods to significantly improve efficacy of breast cancer screening. (Photo courtesy of Hugh scott, University of Oklahoma)
Feature | Women's Health | November 11, 2015 | Jeff Zagoudis
The fight against breast cancer has been a highly...
I-View contrast enhanced 2-D mammography image courtesy of Hologic
Technology | Breast Imaging | October 02, 2015
October 2, 2015 — At the Radiological Society of North America’s (RSNA) 2015 annual meeting, Hologic will emphasize...
News | MRI Breast | September 15, 2015
September 15, 2015 — The Susan G. Komen Illinois Affiliates applaud Rep. Mike Smiddy (D-Hillsdale) on the passage of...
Metastasis occurs when cells are shed from primary breast cancer tumor and establish a new tumor at a distant site. For early detection of the metastasis with MRI, the Lu Lab developed a probe that binds to fibrin-fibronectin protein complexes in high-risk tumors. Fibronectin is expressed in high-risk (aggressive) cancer and not in normal tissue, so MRI imaging is able to distinguish metastases from normal tissue. Image courtesy of the National Institutes of Health.
News | MRI Breast | August 12, 2015
August 12, 2015 — Researchers have shown that...
Technology | December 20, 2013
Siemens Healthcare has announced that the Food and Drug Administration (FDA) has cleared the Magnetom Prisma, a 3...
News | June 27, 2013
QSUM Biopsy Disposables, LLC received a new patent for the AccuFit MRI Coil draping provided for various breast...
